Eyewire News: The Podcast

An executive from Viridian discusses the FDA approval of Lumvoa for thyroid eye disease (TED); a biosimilar referencing Lucentis is relaunched in the US; and Lumibird introduces a wireless integrated laser-indirect-ophthalmoscope. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ocular Therapeutix provides a key update on its NDA plans for wet AMD drug candidate Axpaxli; Thea US launches a first-of-its-kind eye gel for glaucoma; and there were several recent milestones reached in the clinical development of novel drugs for a variety of ocular conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Johnson & Johnson expands the availability of its latest Tecnis lens; Bayer completes its acquisition of Perfuse Therapeutics, expanding its presence in ophthalmology; and ophthalmic leaders discuss how to navigate the current regulatory environment of the FDA. Learn more about your ad choices. Visit megaphone.fm/adchoices

An international study examines the link between a popular weight loss medication and wet AMD risk; Heidelberg receives FDA clearance for a Spectralis software upgrade; and Bausch + Lomb launches its latest over-the-counter dry eye relief product in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices

Oculis Releases phase 3 data for its investigational eye drop for DME; Rayner expands its surgical offerings with the launch of a new OVD; and a biosimilar referencing Eylea is launched in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoices

Outlook Therapeutics takes a major step forward in its plan to gain approval for wet AMD drug Lytenava; the first commercial FLIGHT procedures using the ViaLuxe Laser System are performed in Europe; and Oculus introduces a new AI-assisted tool designed to help clinicians evaluate MGD using meibography images. Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA approves wireless pressure-modulating goggles for at-home glaucoma treatment; Bausch + Lomb launches a new PreserVision AREDS eye vitamin formation; and an Executive Strategic Advisor discusses the regulation environment for communication in eye care.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Leading ophthalmologists join us to discusses the hottest topics in the posterior segment treatment landscape.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Bayer expands ophthalmology pipeline with acquisiton of Perfuse Therapeutics; Viridian announces new phase 3 data for its investigational subcutaneous injection for chronic thyroid eye disease; and Steven Dell, MD discusses the impact of declining reimbursement could on ophthalmic practices. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ophthalmic executives discuss strategies to scale and grow in today’s economic and regulatory environments.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Glaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Eyewire reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery meeting in Washington DC.  Learn more about your ad choices. Visit megaphone.fm/adchoices

A major recall is announced for several store-brand OTC eye drops; the FDA extends dosing intervals for Eylea HD in patients with Wet AMD and DME; and Bausch + Lomb launches its second full range of vision IOL in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharma giant Biogen announces its intention to acquire Apellis in a multi-billion dollar deal; a recently approved first-of-its-kind presbyopia drop is commercially launched; and Kodiak Sciences releases phase 3 data for its diabetic retinopathy drug candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Executive Director of The American Society of Cataract & Refractive Surgery (ASCRS) previews the upcoming annual meeting and discusses the most pressing issues facing ophthalmology.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA agrees to review a presbyopia drop designed to modulate pupil dynamics; a new endocapsular device receives clearance in Europe; and Rayner makes an acquisition to expands its cataract surgery portfolio.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Zeiss releases a software app that aims to address longstanding challenges in ophthalmic care; Oertli launches its new surgical platform, the OS 4 Up, in Europe; and Harrow introduces direct-to-prescriber cash-pay kits for ophthalmic branded medications. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ocular Therapeutix releases its long-awaited SOL-1 phase 3 data for wet AMD drug candidate Axpaxli; Nordic Pharma expands the availability of its novel dry eye therapy Lacrifill; and Alcon launches the only multifocal toric contact lens featuring Water Gradient Technology. Learn more about your ad choices. Visit megaphone.fm/adchoices

New research reveals that a popular diabetes treatment may lower the risk of AMD progression; a study examines the performance of large language models on specialty ophthalmology examinations; and a new doctor-led alliance that aims to support private practice optometrists has officially launched.  Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA approves the first dual-agent eye drop for presbyopia; Rayner launches a personalized, AI-powered patient education platform; and new study examines the link between sleep positioning and eye pressure.  Learn more about your ad choices. Visit megaphone.fm/adchoices

The FDA approves a key label supplement for Glaukos’ iDoseTR; Nidek announces the European launch of a new open-field refraction system; and there have been several leadership changes announced during the first month of 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices

Rayner launches a new phaco system in the US; Eylea 8 mg is approved for a third indication in Europe; and Nanodropper announces a consolidation plan to expand its offerings under a new name.  Learn more about your ad choices. Visit megaphone.fm/adchoices

New research may provide hope for patients with a rare vision-threatening condition; the first daily disposable soft contact lens using EDOF technology for presbyopia is cleared in the US; and there several advancements made in the clinical development of treatment candidates for retinal diseases. Learn more about your ad choices. Visit megaphone.fm/adchoices

Shareholders vote on Alcon’s blockbuster acquisition proposal for Staar Surgical; the FDA responds to Outlook’s latest BLA submission for wet AMD drug Lytenava; and the FDA approves an interchangeable biosimilar to Lucentis.  Learn more about your ad choices. Visit megaphone.fm/adchoices